Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $670.22 | 46 | 96.0% |
| Education | $27.78 | 2 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $221.53 | 14 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.69 | 6 | $0 (2017) |
| PFIZER INC. | $78.48 | 6 | $0 (2018) |
| Astellas Pharma US Inc | $75.46 | 5 | $0 (2017) |
| Novo Nordisk Inc | $47.05 | 3 | $0 (2018) |
| Lilly USA, LLC | $40.30 | 3 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $31.75 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $23.43 | 2 | $0 (2017) |
| Amgen Inc. | $19.36 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $18.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $202.24 | 15 | PFIZER INC. ($67.48) |
| 2017 | $495.76 | 33 | AstraZeneca Pharmaceuticals LP ($161.61) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2018 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/22/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/20/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: DIABETES | ||||||
| 08/14/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/25/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/07/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.75 | General |
| 05/23/2018 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Diabetes | ||||||
| 04/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 02/19/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2017 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| 12/04/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.32 | General |
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 455 | 656 | $153,093 | $45,564 |
| 2022 | 6 | 477 | 695 | $140,286 | $48,386 |
| 2021 | 6 | 447 | 709 | $133,899 | $48,648 |
| 2020 | 6 | 467 | 671 | $118,060 | $32,879 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 212 | 393 | $84,083 | $23,573 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 110 | 110 | $37,524 | $13,713 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 72 | 88 | $12,561 | $3,282 | 26.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 25 | 27 | $11,789 | $2,791 | 23.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2023 | 13 | 13 | $5,375 | $2,068 | 38.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 23 | 25 | $1,761 | $137.72 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 219 | 418 | $79,078 | $24,368 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 120 | 120 | $32,090 | $15,154 | 47.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 24 | 29 | $10,606 | $3,085 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 66 | 74 | $9,565 | $3,010 | 31.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2022 | 16 | 16 | $6,400 | $2,578 | 40.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 32 | 38 | $2,547 | $190.80 | 7.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 217 | 453 | $80,813 | $27,396 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 82 | 82 | $21,216 | $10,475 | 49.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 24 | 24 | $9,244 | $3,899 | 42.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 80 | 97 | $11,798 | $3,816 | 32.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 18 | 26 | $9,100 | $2,902 | 31.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 26 | 27 | $1,728 | $161.50 | 9.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 255 | 439 | $81,477 | $20,739 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 44 | 44 | $10,938 | $4,980 | 45.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2020 | 18 | 18 | $6,715 | $3,027 | 45.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 71 | 89 | $10,288 | $2,566 | 24.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 40 | 41 | $6,530 | $1,129 | 17.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 15 | 15 | $546.16 | $303.02 | 55.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 24 | 25 | $1,566 | $134.64 | 8.6% |
About Dr. Derek Turner, MD
Dr. Derek Turner, MD is a Internal Medicine healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639189384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Turner, MD has received a total of $698.00 in payments from pharmaceutical and medical device companies, with $202.24 received in 2018. These payments were reported across 48 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($670.22).
As a Medicare-enrolled provider, Turner has provided services to 1,846 Medicare beneficiaries, totaling 2,731 services with total Medicare billing of $175,477. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Racine, WI
- Active Since 08/08/2006
- Last Updated 07/10/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639189384
Products in Payments
- FARXIGA (Drug) $221.53
- Myrbetriq (Drug) $75.46
- CHANTIX (Drug) $55.82
- STIOLTO (Drug) $50.85
- JARDIANCE (Drug) $40.34
- XIFAXAN (Drug) $23.43
- Prolia (Biological) $19.36
- DIABETES - DISEASE (Drug) $18.65
- XARELTO (Drug) $18.56
- PENNSAID (Drug) $15.84
- TRULICITY (Drug) $13.91
- SPIRIVA RESPIMAT (Drug) $13.89
- YOSPRALA (Drug) $13.19
- SOLIQUA (Drug) $13.10
- Trulance (Drug) $12.29
- Victoza (Drug) $11.98
- ELIQUIS (Drug) $11.66
- BYSTOLIC (Drug) $11.35
- PREVNAR - 13 (Biological) $11.00
- Reveal LINQ (Device) $10.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Racine
Kaye-Eileen Willard, Md, MD
Internal Medicine — Payments: $114,467
Gregory Culen, M.d, M.D
Internal Medicine — Payments: $5,142
Gerald Wisniewski, Md, MD
Internal Medicine — Payments: $4,673
Paul Durbin, M.d, M.D
Internal Medicine — Payments: $3,033
Dr. Michael Papp, D.o, D.O
Internal Medicine — Payments: $2,141
Dr. Roger Boye, Md, MD
Internal Medicine — Payments: $1,595